Does APIXABAN Cause Skin atrophy? 61 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 61 reports of Skin atrophy have been filed in association with APIXABAN (ELIQUIS). This represents 0.0% of all adverse event reports for APIXABAN.
61
Reports of Skin atrophy with APIXABAN
0.0%
of all APIXABAN reports
2
Deaths
12
Hospitalizations
How Dangerous Is Skin atrophy From APIXABAN?
Of the 61 reports, 2 (3.3%) resulted in death, 12 (19.7%) required hospitalization, and 2 (3.3%) were considered life-threatening.
Is Skin atrophy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for APIXABAN. However, 61 reports have been filed with the FAERS database.
What Other Side Effects Does APIXABAN Cause?
Death (18,501)
Cerebrovascular accident (7,237)
Atrial fibrillation (5,690)
Off label use (5,590)
Thrombosis (5,298)
Fall (5,063)
Cardiac disorder (4,917)
Haemorrhage (4,770)
Dyspnoea (4,379)
Gastrointestinal haemorrhage (4,030)
What Other Drugs Cause Skin atrophy?
DUPILUMAB (262)
PREDNISONE (258)
ADALIMUMAB (205)
METHOTREXATE (191)
ETANERCEPT (139)
CLOBETASOL (123)
SECUKINUMAB (121)
IBRUTINIB (112)
TRIAMCINOLONE ACETONIDE (110)
HYDROCORTISONE (106)
Which APIXABAN Alternatives Have Lower Skin atrophy Risk?
APIXABAN vs APOMORPHINE
APIXABAN vs APRACLONIDINE
APIXABAN vs APREMILAST
APIXABAN vs APREPITANT
APIXABAN vs APROTININ